Research: Genzyme

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

Pharmaceutical Business Review

2009-09-09 12:04
Genzyme To Launch Three Drugs In India
Company intend to bring entire range of products to Inida within the next three years

2009-08-31 12:04
US Drug Reviewers Question Genzyme Study For Clolar
Genzyme is seeking permission to promote the drug to adults with AML

2009-08-20 12:03
Holzer Holzer & Fistel Files Class Action Lawsuit Against Genzyme
Genzyme failed to disclose certain problems it was experiencing at two of its manufacturing facilities

2009-08-06 04:03
Genzyme Receives Approval From European Commission For Mozobil
Genzyme has filed applications for the approval of Mozobil in Argentina, Australia, Brazil, Israel, and Singapore

2009-08-04 12:03
Glancy Binkow & Goldberg Files Lawsuit Against Genzyme
Lawsuit alleges that throughout the Class Period, defendants failed to disclose serious problems and operational deficiencies

2009-08-03 12:03
Izard Nobel Files Class Action Lawsuit Against Genzyme
Lawsuit alleges that defendants violated security laws

2009-08-03 04:03
Genzyme Provides Update On Allston Landing Plant
To verify that corrective and preventative actions identified in a February warning letter, have been implemented

2009-06-17 12:04
Genzyme Temporarily Stops Production At Allston Plant
Expects to be fully operational by the end of July

2009-06-15 12:03
Genzyme Obtains European Approval For Renvela
Renvela,a calcium-free, metal-free, non-absorbed phosphate binder, and a carbonate buffer

2009-06-03 12:03
Bayer, Genzyme Finalize Strategic Alliance
Genzyme is all set to market and sell Campath MabCampath (alemtuzumab), Fludara (fludarabine) and Leukine (sargramostim), globally.